Advertisement
Perrigo Guides FY24 Well Below Estimates - Update
(RTTNews) - While reporting financial results for the fourth quarter on Tuesday, consumer products company Perrigo Co. plc (PRGO) initiated its adjusted earnings, revenue and organic net sales growth guidance for the full-year 2024.
For fiscal 2024, the company now projects adjusted earnings in a range of $2.50 to $2.65 per share on flat net sales, with organic net sales growth of 1 to 3 percent.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.99 per share on revenue growth of 4.7 percent to $4.89 billion for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
Perrigo Recalls Select CVS Health, H-E-B Baby Premium Infant Formula
Perrigo Co. plc is recalling select Premium Infant Formula with Iron Milk-Based Powder sold under CVS Health and H-E-B Baby brands at the retailer and warehouse level citing elevated Vitamin D levels than permitted, according to the U.S. Food and Drug Administration. The recall involves three lots within one batch, or 16,500 cans, of store brand Premium Infant Formula with Iron Milk-Based Powder.
RTTNews
|
373 dagar sedan
Perrigo Launches Project Energize To Improve Efficiency, Cut Costs; To Cut 6% Jobs - Update
While reporting financial results for the fourth quarter on Tuesday, consumer products company Perrigo Co. plc (PRGO) said it is launching Project Energize - a global investment and efficiency program to drive the next evolution of capabilities and organizational agility.
RTTNews
|
537 dagar sedan
Perrigo Appoints Patrick Lockwood-Taylor As President And CEO
Pharma company Perrigo Company plc (PRGO) announced Thursday the appointment of industry professional Patrick Lockwood-Taylor as its new President, Chief Executive Officer and member of the Board of Directors, effective June 30, 2023.
RTTNews
|
801 dagar sedan
Perrigo Says HRA Pharma Submits Application To FDA For OTC Birth Control Pill In The U.S.
Consumer Self-Care Products firm Perrigo Co. plc (PRGO) announced Monday that its company HRA Pharma has submitted its application to the U.S. Food and Drug Administration (FDA) for the first-ever over-the-counter (OTC) birth control pill in the U.S.
RTTNews
|
1133 dagar sedan
Euro Higher Against Majors
The euro appreciated against its major counterparts in the New York session on Friday.
RTTNews
|
1 dag sedan
TSX Down Marginally In Lackluster Trade
Canadian stocks are turning in a mixed performance in somewhat lackluster trade on Friday, with investors focusing on the upcoming US - Russia summit that could help end the war in Ukraine.
RTTNews
|
2 dagar sedan
Swiss Market Ends On Firm Note
The Switzerland market ended on a firm note on Friday with stocks from across several sectors gaining ground on sustained buying support. The mood remained positive right through the day's session, amid some expectations about an end to the Ukraine war.
RTTNews
|
2 dagar sedan
European Stocks Close Mixed After Cautious Session
European stocks closed on a mixed note on Friday with investors largely staying cautious, awaiting the meeting of the Presidents of the U.S. and Russia, and continuing to assess Trump administration's tariff moves and their impact on global economic growth.
RTTNews
|
2 dagar sedan
